Frankfurt - Delayed Quote EUR

Soleno Therapeutics, Inc. (6XC.F)

Compare
42.14
0.00
(0.00%)
At close: January 10 at 3:29:01 PM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
138,469.00
38,670.00
25,109.00
32,259.00
31,949.00
Operating Income
-138,469.00
-38,670.00
-25,109.00
-32,259.00
-31,949.00
Net Non Operating Interest Income Expense
10,831.00
2,578.00
300.00
110.00
13.00
Other Income Expense
-3,526.00
-2,896.00
742.00
1,239.00
7,297.00
Pretax Income
-131,164.00
-38,988.00
-24,067.00
-30,910.00
-24,639.00
Net Income Common Stockholders
-131,164.00
-38,988.00
-24,067.00
-30,910.00
-24,639.00
Diluted NI Available to Com Stockholders
-131,164.00
-38,988.00
-24,067.00
-30,910.00
-24,639.00
Basic EPS
-2.79
-2.36
-2.87
-5.81
-5.85
Diluted EPS
-2.79
-2.36
-2.87
-5.81
-5.85
Basic Average Shares
37,847.62
16,492.13
8,397.09
5,318.02
4,174.68
Diluted Average Shares
37,847.62
16,492.13
8,397.09
5,318.02
4,174.68
Total Operating Income as Reported
-142,465.00
-41,384.00
-24,397.00
-31,528.00
-36,289.00
Total Expenses
138,469.00
38,670.00
25,109.00
32,259.00
31,949.00
Net Income from Continuing & Discontinued Operation
-131,164.00
-38,988.00
-24,067.00
-30,910.00
-24,639.00
Normalized Income
-127,638.00
-36,092.00
-24,809.00
-32,149.00
-31,936.00
Interest Income
10,831.00
2,578.00
300.00
110.00
13.00
Net Interest Income
10,831.00
2,578.00
300.00
110.00
13.00
EBIT
-138,469.00
-38,670.00
-25,109.00
-32,259.00
-31,949.00
EBITDA
-136,496.00
-36,712.00
-23,145.00
-30,296.00
-29,995.00
Reconciled Depreciation
1,973.00
1,958.00
1,964.00
1,963.00
1,954.00
Net Income from Continuing Operation Net Minority Interest
-131,164.00
-38,988.00
-24,067.00
-30,910.00
-24,639.00
Total Unusual Items Excluding Goodwill
-3,526.00
-2,896.00
742.00
1,239.00
7,297.00
Total Unusual Items
-3,526.00
-2,896.00
742.00
1,239.00
7,297.00
Normalized EBITDA
-132,970.00
-33,816.00
-23,887.00
-31,535.00
-37,292.00
12/31/2020 - 8/28/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

UQ1.F uniQure N.V.
15.23
+0.03%
 
0K4.F Akero Therapeutics, Inc.
25.36
+0.71%
 
CXF.MU Chimerix Inc
3.1700
-5.09%
 
RADX Radiopharm Theranostics Limited
5.35
+30.17%
 
CGEM Cullinan Therapeutics, Inc.
11.19
+0.54%
 
RZLT Rezolute, Inc.
4.9000
-5.95%
 
OCS Oculis Holding AG
21.15
+13.10%
 
WVE Wave Life Sciences Ltd.
11.54
-7.68%
 
CYBN Cybin Inc.
8.89
-7.01%
 
JANX Janux Therapeutics, Inc.
46.76
-7.99%